June 27, 2025 Release Highlights Copied

06/27/20252025 VBCRelease note

Practice Insights is pleased to announce updates in the application to support the Merit-Based Incentive Payment System (MIPS) and Enhancing Oncology Model (EOM).

MIPS Quality Measures Dashboard

The MIPS Quality Measures Dashboard will be updated to reflect the following refinement(s):

Measure Description Practice Impact
PIMSH 18: Resolution or Improvement of a Health-Related Social Need This is a new QCDR measure gauging patients who screen for 1 or more of the 5 core health-related social needs that have at least 1 of their social needs resolved or improved.

Denominator includes all patients 18 years or older who screened positive for 1 or more of the 5 core domains included in a standardized HRSN screening.

  • Requires two patient encounters during the performance period.
  • Denominator Exception:
    • Patient Declined assessment
    • Patient declined assistance
  • Denominator Exclusion:
    • Patients who have died prior to 6-month follow up
    • Patients who are actively enrolled in hospice during the 6-month follow up

Numerator includes patients who report resolution of at least 1 health-related social need or improvement to distress score within 6 months

 Establish a numerator and denominator for this new measure.

New measures in their first year of reporting.
MIPS 134 eCQM: Preventive Care Screening: Screening for Depression and Follow Up Plan Numerator: Added referral date condition to capture that the depression referral date should be documented within 2 days of the depression screening

Note: Timeframe references 2 consecutive calendar days

 Practices will notice a shift in the denominator and numerator
MIPS 134 CQM/Registry: Preventive Care Screening: Screening for Depression and Follow Up Plan Denominator:

  • Added new CPT codes and removed obsolete CPT codes
  • Removed Telehealth Modifier 95 code

Denominator Exclusion:

  • Removed ICD9 codes for bipolar disorder

 

Numerator:

Added referral date condition to capture that the depression referral date should be documented within 2 days of the depression screening

Note: Timeframe references 2 consecutive calendar days

 Practices will notice a shift in the denominator and numerator

EOM Performance Measures Dashboard

The EOM Performance Measures Dashboard will be updated to reflect the following refinement(s):

Measure Description Practice Impact
EOM-5: Preventive Care Screening: Screening for Depression and Follow Up Plan Denominator:

  • Added new CPT codes and removed obsolete CPT codes
  • Removed Telehealth Modifier 95 code

Denominator Exclusion:

  • Removed ICD9 codes for bipolar disorder

Numerator:

Added referral date condition to capture that the depression referral date should be documented within 2 days of the depression screening

Note: Timeframe references 2 consecutive calendar days

 Practices will notice a shift in the denominator and numerator

Status of Dashboard Updates for 2025

CMS releases updates to the quality measure specifications annually for the MIPS program. These measure specifications have been reviewed, and Practice Insights is working on the required technical updates to align with the revised requirements. Ontada will continue to notify practices once measures have been updated based on the current 2025 requirements.

Measure Description
MIPS Quality Measures Dashboard
MIPS #001 Diabetes Hemoglobin A1c (HbA1cc) Poor Control (>9%) (Inverse Measure)
MIPS #047 Advance Care Plan
MIPS #130 Current Medications Documentation
MIPS #134 eCQM Preventive Care Screening: Screening for Depression and Follow Up Plan
MIPS #134 CQM/Registry Preventive Care Screening: Screening for Depression and Follow Up Plan
MIPS #143 Pain Intensity Quantified
MIPS #144 Pain Care Plan
MIPS #226 Tobacco Screening and Cessation
MIPS #236 Controlling High Blood Pressure
MIPS #238 Use of High-Risk Medications in Older Adults (Inverse Measure)
MIPS #374 Closing the Referral Loop
MIPS #450 Appropriate Treatment for Patients with Stage I (T1c) III Her2 Positive Breast Cancer
MIPS #451 RAS (KRAS & NRAS) Testing Performed for Patients with Metastatic Colorectal Cancer who Receive Anti-EGFR Monoclonal Antibody Therapy
MIPS #453 Proportion Receiving Chemotherapy in the Last 14 Days of Life (Inverse Measure)
MIPS #457 Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 Days
MIPS #462 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
MIPS #487 Screening for Social Drivers of Health
PIMSH #1 Advance Care Planning in Metastatic Disease
PIMSH #9 Supportive Care Drug Utilization in the Last 14 Days of Life (Inverse Measure)
PIMSH #10 Hepatitis B Serology Testing and Prophylactic Treatment Prior to Receiving Anti-CD20 Targeting Drugs
PIMSH #13 Proportion of Stage IV nsNSCLC Patients Tested for Actionable Biomarkers and Received Mutation-Targeted Therapy
PIMSH #15 Antiemetic Therapy for Low-and Minimal-Emetic-Risk Antineoplastic Agents in the Infusion Center-Avoidance of Overuse (Inverse Measure)
PIMSH #16 Appropriate Antiemetic Therapy for High-and Moderate-Emetic-Risk Antineoplastic Agents in the Infusion Center
PIMSH #17 Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (Inverse Measure)
PIMSH #18 Resolution or Improvement of a Health-Related Social Need
EOM Performance Measures Dashboard
EOM-4A Pain Intensity Quantified
EOM-4B Pain Care Plan
EOM-5 Preventive Care Screening: Screening for Depression and Follow Up Plan